Dinçarslan, H. Et Al. 2018. The first report related to first-line therapy with anti-CD30 combined Hodgkin disease underlying combined deficiency. 50th Congress of the International Society of Paediatric Oncology (SIOP) , (Kyoto, Japan).

Dinçarslan, H., ÜNAL, E., TAÇYILDIZ, N., Tanyıldız, G., KULOĞLU, Z., Kaygusuz, G., ... ÇAKMAK, A. M.(2018). The first report related to first-line therapy with anti-CD30 combined Hodgkin disease underlying combined deficiency . 50th Congress of the International Society of Paediatric Oncology (SIOP), Kyoto, Japan

Dinçarslan, Handan Et Al. "The first report related to first-line therapy with anti-CD30 combined Hodgkin disease underlying combined deficiency," 50th Congress of the International Society of Paediatric Oncology (SIOP), Kyoto, Japan, 2018

Dinçarslan, Handan Et Al. "The first report related to first-line therapy with anti-CD30 combined Hodgkin disease underlying combined deficiency." 50th Congress of the International Society of Paediatric Oncology (SIOP) , Kyoto, Japan, 2018

Dinçarslan, H. Et Al. (2018) . "The first report related to first-line therapy with anti-CD30 combined Hodgkin disease underlying combined deficiency." 50th Congress of the International Society of Paediatric Oncology (SIOP) , Kyoto, Japan.

@conferencepaper{conferencepaper, author={Handan Dinçarslan Et Al. }, title={The first report related to first-line therapy with anti-CD30 combined Hodgkin disease underlying combined deficiency}, congress name={50th Congress of the International Society of Paediatric Oncology (SIOP)}, city={Kyoto}, country={Japan}, year={2018}}